학술논문
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 -Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study.
Document Type
journal article
Author
Source
Journal of Clinical Oncology; 9/1/2019, Vol. 37 Issue 25, p2235-2245, 18p
Subject
Language
ISSN
0732183X